Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Dyer

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
American Journal of Human Genetics|June 15, 2006
Human genomic deletions mediated by recombination between Alu elementsShurjo K Sen, Kyudong Han, Jianxin Wang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 14, 2006
Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK)Linda D Sharples, Matthew Dyer, Fay Cafferty, et al.
Journal of Comparative Effectiveness Research|July 11, 2023
Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinomaSvenja Petersohn, Bradley McGregor, Sven L Klijn, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 20, 2007
Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK)Linda D Sharples, Fay Cafferty, Nickolaos Demitis, et al.
British Journal of Haematology|October 27, 2025
Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent β-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trialKhaled M Musallam, Ali T Taher, John B Porter, et al.
European Journal of Haematology|March 20, 2026
Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND TrialKhaled M Musallam, Maria Domenica Cappellini, Antonis Kattamis, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
American Journal of Human Genetics|June 15, 2006
Human genomic deletions mediated by recombination between Alu elementsShurjo K Sen, Kyudong Han, Jianxin Wang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 14, 2006
Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK)Linda D Sharples, Matthew Dyer, Fay Cafferty, et al.
Journal of Comparative Effectiveness Research|July 11, 2023
Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinomaSvenja Petersohn, Bradley McGregor, Sven L Klijn, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 20, 2007
Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK)Linda D Sharples, Fay Cafferty, Nickolaos Demitis, et al.
British Journal of Haematology|October 27, 2025
Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent β-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trialKhaled M Musallam, Ali T Taher, John B Porter, et al.
European Journal of Haematology|March 20, 2026
Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND TrialKhaled M Musallam, Maria Domenica Cappellini, Antonis Kattamis, et al.
Pageof 3